Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sörgel

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Chemotherapy|April 16, 2004
The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthdayF Sörgel
Reviews of Infectious Diseases|July 1, 1989
Metabolism of gyrase inhibitorsF Sörgel
International Journal of Clinical Pharmacology and Therapeutics|May 29, 2009
Biosimilars / Follow-on proteins - a case for clinical pharmacologyF Sörgel
Clinical Pharmacokinetics|January 1, 1992
Penetration of temafloxacin into body tissues and fluidsF Sörgel
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Ciprofloxacin in the treatment of complicated urinary tract infectionsK Naber, F Sörgel
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infectionsF Sörgel, M Kinzig
The American Journal of Medicine|March 22, 1993
Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactionsF Sörgel, M Kinzig
Intensive Care Medicine|July 1, 1994
Pharmacokinetic characteristics of piperacillin/tazobactamF Sörgel, M Kinzig
Clinical Pharmacokinetics|July 1, 1995
Clinical pharmacokinetics in patients with burnsU Jaehde, F Sörgel
The Journal of Antimicrobial Chemotherapy|January 1, 1993
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactamF Sörgel, M Kinzig
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Chemotherapy|April 16, 2004
The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthdayF Sörgel
Reviews of Infectious Diseases|July 1, 1989
Metabolism of gyrase inhibitorsF Sörgel
International Journal of Clinical Pharmacology and Therapeutics|May 29, 2009
Biosimilars / Follow-on proteins - a case for clinical pharmacologyF Sörgel
Clinical Pharmacokinetics|January 1, 1992
Penetration of temafloxacin into body tissues and fluidsF Sörgel
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Ciprofloxacin in the treatment of complicated urinary tract infectionsK Naber, F Sörgel
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infectionsF Sörgel, M Kinzig
The American Journal of Medicine|March 22, 1993
Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactionsF Sörgel, M Kinzig
Intensive Care Medicine|July 1, 1994
Pharmacokinetic characteristics of piperacillin/tazobactamF Sörgel, M Kinzig
Clinical Pharmacokinetics|July 1, 1995
Clinical pharmacokinetics in patients with burnsU Jaehde, F Sörgel
The Journal of Antimicrobial Chemotherapy|January 1, 1993
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactamF Sörgel, M Kinzig
Pageof 14